期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
抗癫癎药物应用指南Ⅰ:新型抗癫癎药物的药力和安全性:新发癫癎的治疗 美国神经病学学会治疗学和技术评定分委会和质量标准分委会及美国癫癎协会报告 被引量:5
1
作者 高枚春 陆钦池 +23 位作者 J.A.French A.M.Kanner J.Bautista B.Abou-Khalil T.Browne C.L.Harden W.H.Theodore C.Bazil J.Stern S.C.Schachter D.Bergen D.hirtz G.D.Montouris M.Nespeca B.Gidal W.J.Marks W.R.Turk J.H.Fischer B.Bourgeois A.Wilner R.E.Faught R.C.Sachdeo A.Beydoun T.A.Glauser 《神经病学与神经康复学杂志》 2008年第3期190-197,共8页
目的对有关7种用以治疗儿童和成人新诊断部分性和全身性癫癎的新型抗癫癎药物(AEDs):加巴喷丁(gabapentin,GBP)、拉莫三嗪(lamotrigine,LTG)、托吡酯(topiramate,TPM)、噻加宾(tiagabine,TGB)、奥卡西平(oxcarbazepine,OXC)、左乙拉西坦... 目的对有关7种用以治疗儿童和成人新诊断部分性和全身性癫癎的新型抗癫癎药物(AEDs):加巴喷丁(gabapentin,GBP)、拉莫三嗪(lamotrigine,LTG)、托吡酯(topiramate,TPM)、噻加宾(tiagabine,TGB)、奥卡西平(oxcarbazepine,OXC)、左乙拉西坦(levetiracetam,LEV)和唑尼沙胺(zonisamide,ZNS)的药力(efficacy)、耐受性和安全性按序进行评估(这些药物已受到美国食品与药品管理局FDA的批准)。方法由23位成人神经病学家、儿科神经病学家、癫癎病学家及药理学家组成的,依据从1987年到2002年9月Medline,Current Contents和Cochrane上发表的相关文献和2003年以前的指南提供的证据进行专家组循证医学评估。结果有证据通过对照试验或剂量控制试验显示:加巴喷丁、拉莫三嗪、托吡酯和奥卡西平单药治疗对新诊断的青少年和成人部分性或混合性癫癎是有效的。亦有证据显示,拉莫三嗪对于新诊断的儿童失神发作有效。但尚缺乏证据证明新型抗癫癎药物对新诊断的其他类型的全身性癫癎综合征是否有效。结论循证医学评估结果提供了新诊断癫癎患者的抗癫癎药物应用指南,但尚需更多的证据用以鉴定其在癫癎的类型或综合征中的疗效。 展开更多
关键词 抗癫药物 新诊断 噻加宾 加巴喷丁 癫癎 卡马西平 托吡酯 妥泰 拉莫三嗪 利必通 抗癫癎药物 丙戊酸盐 苯妥英钠 抗心律失常药 奥卡西平 部分性 应用指南 技术评定 治疗学 临床医学 质量
原文传递
抗癫癎药物应用指南Ⅱ:新型抗癫癎药物的药力和耐受性:难治性癫癎的治疗美国神经病学学会治疗学和技术评定分委会和质量标准分委会及美国癫癎协会报告 被引量:1
2
作者 陆钦池 冯智英 +27 位作者 李颖 季伟华 J.A.French A.M.Kanner J.Bautista B.Abou-Khalil T.Browne C.L.Harden W.H.Theodore C.Bazil J.Stern S.C.Schachter D.Bergen D.hirtz G.D.Montouris M.Nespeca B.Gidal W.J.Marks Jr. W.R.Turk J.H.Fischer B.Bourgeois A.Wilner R.E.Faught Jr. R.C.Sachdeo A.Beydoun T.A.Glauser 《神经病学与神经康复学杂志》 2008年第4期265-277,共13页
目的对有关7种用以治疗儿童和成人部分性和全面性难治性癫癎的新型抗癫癎药物(AEDs):加巴喷丁(gabapentin, GBP)、拉莫三嗪(lamotrigine,LTG)、托吡酯(topiramate,TPM)、噻加宾(tiagabine,TGB)、奥卡西平(oxcarbazepine,OXC)、左乙拉西... 目的对有关7种用以治疗儿童和成人部分性和全面性难治性癫癎的新型抗癫癎药物(AEDs):加巴喷丁(gabapentin, GBP)、拉莫三嗪(lamotrigine,LTG)、托吡酯(topiramate,TPM)、噻加宾(tiagabine,TGB)、奥卡西平(oxcarbazepine,OXC)、左乙拉西坦(levetiracetam,LEV)和唑尼沙胺(zonisamide,ZNS)的药力(efficacy)、耐受性和安全性进行评估。方法由23位成人神经病学家、小儿神经病学家、癫癎病学家和药理学家组成的专家组,依据从1987年到2002年9月Medline,Current Contents和Cochrane上发表的相关文献和2003年以前的指南提供的证据进行循证医学评估。结果所有新型抗癫癎药物都适用于成人难治性部分性癫癎的添加治疗,加巴喷丁对混合性癎性发作有效,加巴喷丁、拉莫三嗪、托吡酯和奥卡西平对儿童难治性部分性癫癎有效。有限的证据还表明,拉莫三嗪和托吡酯对成人和儿童特发性全面性发作和Lennox-Gastaut综合征的添加治疗也有效。结论抗癫癎药物的选择要考虑癫癎发作和/或癫癎综合征的类型、患者的年龄、合用的药物、药物的耐受性、安全性和药力等因素。循证医学评估结果提供了难治性癫癎患者的抗癫癎药物应用指南,但尚需更为有力的证据用以鉴定其在癫癎型或综合征中疗效。 展开更多
关键词 药物 应用指南 耐受性 难治性癫 治疗学 美国 神经病学 技术评定 质量 标准分 ANTIEPILEPTIC drugs new society american quality technology refractory epilepsy 拉莫三嗪 加巴喷丁 托吡酯
原文传递
Framework for TCAD augmented machine learning on multi-I-V characteristics using convolutional neural network and multiprocessing
3
作者 Thomas hirtz Steyn Huurman +2 位作者 He Tian Yi Yang Tian-Ling Ren 《Journal of Semiconductors》 EI CAS CSCD 2021年第12期86-94,共9页
In a world where data is increasingly important for making breakthroughs,microelectronics is a field where data is sparse and hard to acquire.Only a few entities have the infrastructure that is required to automate th... In a world where data is increasingly important for making breakthroughs,microelectronics is a field where data is sparse and hard to acquire.Only a few entities have the infrastructure that is required to automate the fabrication and testing of semiconductor devices.This infrastructure is crucial for generating sufficient data for the use of new information technologies.This situation generates a cleavage between most of the researchers and the industry.To address this issue,this paper will introduce a widely applicable approach for creating custom datasets using simulation tools and parallel computing.The multi-I-V curves that we obtained were processed simultaneously using convolutional neural networks,which gave us the ability to predict a full set of device characteristics with a single inference.We prove the potential of this approach through two concrete examples of useful deep learning models that were trained using the generated data.We believe that this work can act as a bridge between the state-of-the-art of data-driven methods and more classical semiconductor research,such as device engineering,yield engineering or process monitoring.Moreover,this research gives the opportunity to anybody to start experimenting with deep neural networks and machine learning in the field of microelectronics,without the need for expensive experimentation infrastructure. 展开更多
关键词 machine learning neural networks semiconductor devices simulation
下载PDF
Neuronal photoactivation through secondharmonic near-infrared absorption by gold nanoparticles 被引量:2
4
作者 Wieteke D.A.M.de Boer Jan J.hirtz +6 位作者 Antonio Capretti Tom Gregorkiewicz Mercè Izquierdo-Serra Shuting Han Christophe Dupre Yuriy Shymkiv Rafael Yuste 《Light(Science & Applications)》 SCIE EI CAS CSCD 2018年第1期79-91,共13页
Optical activation of neurons requires genetic manipulation or the use of chemical photoactivators with undesirable side effects.As a solution to these disadvantages,here,we demonstrate optically evoked neuronal activ... Optical activation of neurons requires genetic manipulation or the use of chemical photoactivators with undesirable side effects.As a solution to these disadvantages,here,we demonstrate optically evoked neuronal activity in mouse cortical neurons in acute slices and in vivo by nonlinear excitation of gold nanoparticles.In addition,we use this approach to stimulate individual epitheliomuscular cells and evoke body contractions in Hydra vulgaris.To achieve this,we use a low-power pulsed near-infrared excitation at the double-wavelength of the plasmon resonance of gold nanoparticles,which enables optical sectioning and allows for high spatial precision and large penetration depth.The effect is explained by second-harmonic Mie scattering,demonstrating light absorption by a second-order nonlinear process,which enables photothermal stimulation of the cells.Our approach also minimizes photodamage,demonstrating a major advancement towards precise and harmless photoactivation for neuroscience and human therapeutics. 展开更多
关键词 activation HARMONIC ABSORPTION
原文传递
人结肠CFTR Cl-通道功能与囊性纤维化的基因型和表型相关
5
作者 hirtz S. Gonska T. +1 位作者 Seydewitz H.H. 王志宇 《世界核心医学期刊文摘(胃肠病学分册)》 2005年第3期34-34,共1页
Background &Aims: Cystic fibrosis (CF) is caused by over 1000 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and presents with a widely variable phenotype. Genotype phenotype stud... Background &Aims: Cystic fibrosis (CF) is caused by over 1000 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and presents with a widely variable phenotype. Genotype phenotype studies identified CFTR mutations that were associated with pancreatic sufficiency (PS). Residual Cl-channel function was shown for selected PS mutations in heterologous cells. However, the functional consequences of most CFTR mutations in native epithelia are not well established. Methods: To elucidate the relationships between epithelial CFTR function, CFTR genotype, and patient phenotype, we measured cyclic adenosine monophosphate (cAMP)mediated Cl-secretion in rectal biopsy specimens from 45 CF patients who had at least 1 non F508 mutation carrying a wide spectrum of CFTR mutations. We compared CFTR genotypes and clinical manifestations of CF patients who expressed residual CFTR mediated Cl-secretion with patients in whom Cl-secretion was absent. Results: Residual anion secretion was detected in 40%of CF patients, and was associated with later disease onset (P <0.0001), higher frequency of PS (P <0.0001), and less severe lung disease (P <0.05). Clinical outcomes correlated with the magnitude of residual CFTR activity, which was in the range of 12%-54%of controls. Conclusions: Specific CFTR mutations confer residual CFTR function to rectal epithelia, which is related closely to a mild disease phenotype. Quantification of rectal CFTR mediated Cl-secretion may be a sensitive test to predict the prognosis of CF disease and identify CF patients who would benefit from therapeutic strategies that would increase residual CFTR activity. 展开更多
关键词 CFTR Cl-通道 通道功能 囊性纤维化 表型相关 基因突变 分泌水平 活检标本 上皮细胞 胰腺功能 肠上皮
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部